Table 2.
Clinical characteristics of study participants (N = 660)
| Characteristic | n | % |
|---|---|---|
| Body mass Index Kg/M2 | ||
| Underweight | 173 | 26.3 |
| Normal | 398 | 60.4 |
| Missing (n = 1)a | ||
| Overweight | 66 | 10.0 |
| Obesity | 22 | 3.3 |
| Polyuria | 110 | 16.7 |
| Polyphagia | 68 | 10.3 |
| Polydipsia | 82 | 12.4 |
| Nocturia | 151 | 22.9 |
| Loss of weight | 479 | 72.6 |
| Fatigue | 375 | 56.8 |
| Blurred vision | 100 | 15.2 |
| Fasting blood glucose levels in mmol/L (n-635) | ||
| Normal | 453 | 71.3 |
| Impaired fasting glucose | 147 | 23.1 |
| Diabetes | 35 | 5.5 |
| Oral glucose tolerance test (n = 147) | ||
| Normal | 110 | 74.1 |
| Impaired glucose tolerance | 33 | 23.1 |
| Diabetes | 4 | 2.8 |
| Sputum Acid fast bacilli status | ||
| Positive | 398 | 60.3 |
| Tuberculosis anatomical site | ||
| Pulmonary | 577 | 87.4 |
| TB treatment category | ||
| First line | 578 | 87.6 |
| First line re-treatment | 68 | 10.3 |
| Second line | 14 | 2.1 |
| Tuberculosis treatment phase | ||
| Intensive | 269 | 40.8 |
| Continuation | 391 | 59.2 |
| HIV sero-status | ||
| Positive | 212 | 32.1 |
| On HIV treatment | ||
| Yes | 191 | 90.1 |
aHeight could not be measured, as patient was unable to stand upright